Literature DB >> 8970421

Impact on ventricular function and quality of life of transcatheter ablation of the atrioventricular junction in chronic atrial fibrillation with a normal ventricular response.

A Natale1, L Zimerman, G Tomassoni, M Kearney, V Kent, M J Brandon, K Newby.   

Abstract

We assessed left ventricular function and quality of life after atrioventricular junction ablation and pacemaker implant in 14 patients with chronic atrial fibrillation and normal ventricular response. A significant improvement in left ventricular ejection fraction, fractional shortening, and functional capacity were observed at follow-up, suggesting that in patients with chronic atrial fibrillation a regular heart beat may be preferable over rate control.

Entities:  

Mesh：

Year:  1996        PMID： 8970421     DOI： 10.1016/s0002-9149(97)89296-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  20 in total

Review 1.  Novel catheter technology for ablative cure of atrial fibrillation.

Authors:  M D Lesh; P Guerra; F X Roithinger; Y Goseki; C Diederich; W H Nau; M Maguire; K Taylor
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

2.  Quality of life in patients with silent atrial fibrillation.

Authors:  I Savelieva; M Paquette; P Dorian; B Lüderitz; A J Camm
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

Review 3.  Science, medicine, and the future: Radiofrequency ablation for atrial fibrillation.

Authors:  N R Grubb; S Furniss
Journal:  BMJ       Date:  2001-03-31

Review 4.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 5.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 6.  Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.

Authors:  Michiel Rienstra; Steven A Lubitz; Saagar Mahida; Jared W Magnani; João D Fontes; Moritz F Sinner; Isabelle C Van Gelder; Patrick T Ellinor; Emelia J Benjamin
Journal:  Circulation       Date:  2012-06-12       Impact factor: 29.690

7.  [Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference].

Authors:  P Kirchhof; A Goette; G Hindricks; S Hohnloser; K-H Kuck; T Meinertz; U Ravens; G Steinbeck; G Breithardt
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-12

8.  Ventricular performance and quality of life in patients who underwent radiofrequency AV junction ablation and permanent pacemaker implantation due to medically refractory atrial tachyarrhythmias.

Authors:  A G Manolis; A G Katsivas; E E Lazaris; C V Vassilopoulos; N E Louvros
Journal:  J Interv Card Electrophysiol       Date:  1998-03       Impact factor: 1.900

9.  Endothelial dysfunction in hypertensive patients and in normotensive offspring of subjects with essential hypertension.

Authors:  B Zizek; P Poredos; V Videcnik
Journal:  Heart       Date:  2001-02       Impact factor: 5.994

10.  Importance of rate control or rate regulation for improving exercise capacity and quality of life in patients with permanent atrial fibrillation and normal left ventricular function: a randomised controlled study.

Authors:  T Levy; S Walker; M Mason; P Spurrell; S Rex; S Brant; V Paul
Journal:  Heart       Date:  2001-02       Impact factor: 5.994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.